501
Views
8
CrossRef citations to date
0
Altmetric
Articles

Enzymatic Hydrolysis Optimization for Preparation of Tuna Dark Meat Hydrolysate with Antioxidant and Angiotensin I-Converting Enzyme (ACE) Inhibitory Activities

, ORCID Icon, ORCID Icon & ORCID Icon
 

ABSTRACT

The hydrolysates of tuna dark meat with high angiotensin I-converting enzyme (ACE) inhibitory and antioxidant activities were prepared using three enzymes. The effect of concentration (0.5–3.0%, w/w) and hydrolysis time (30–180 min) on yield, degree of hydrolysis (DH), ACE inhibitory activities, and antioxidant capacity was determined. The optimum conditions were the same: 180 min extraction while the concentration of alcalase, neutrase, and flavourzyme were 2.43, 2.62, and 2.62% (w/w), respectively. The hydrolysate resulted in the range of 36.5–50.0% for DH, 5.79–7.71% for yield, 0.29–1.11, 0.28–0.53, and 0.24–0.31 mg/mL IC50 values with 2,2-diphenyi-l-picrylhydrazyl radical (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), and ACE inhibitory activity, respectively, and 0.41–1.35 FeSO4/g for ferric reducing antioxidant power (FRAP). The hydrolysates showed high solubility. Emulsion stability and emulsifying activity index decreased, while foam stability and expansion increased with increasing concentration. Hydrolysates using flavourzyme were fractioned using ultrafiltration membranes. The <1 kDa fraction had significantly higher ACE inhibitory and antioxidant activities.

Acknowledgments

The authors gratefully acknowledge the financial support of the National Research Council of Thailand (NRCT) provided by Chiang Mai University (Thailand) and the Thailand Graduate Institute of Science and Technology (TGIST), the National Science and Technology Development Agency (TGIST: TG-22-10-60-032M) to the authors to do the practical work reported in this paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.